-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Omega Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q3 2022 to Q2 2024.
- Omega Therapeutics, Inc. Revenues for the quarter ending June 30, 2024 was $2.13M, a 181% increase year-over-year.
- Omega Therapeutics, Inc. Revenues for the twelve months ending June 30, 2024 was $6.31M.
- Omega Therapeutics, Inc. annual Revenues for 2023 was $3.09M, a 49.3% increase from 2022.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)